Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biossance is a commercial clean-skincare brand focused on science-backed, vegan skin care products built around sugarcane-derived squalane. The brand was originally developed out of Amyris's industrial biotechnology capabilities and emphasizes sustainable ingredient sourcing, fermentation-enabled formulation, and prestige skincare positioning. Its product portfolio includes moisturizers, serums, cleansers, sunscreens, eye treatments, oils, masks, and lip care sold direct-to-consumer and through retail partners. In December 2023, Biossance was acquired by THG from Amyris following Amyris's Chapter 11 proceedings, and the brand continues to operate as an active prestige skincare business under THG Beauty.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biossance.